Abiopharma

🔍 Gulfo Adele M. (Director)

Company: Enpro Inc. (NPO)

Report Date: 2026-06-17

Detailed Transactions and Holdings:

• Acquired 4 shares of Phantom Stock (Derivative)
  Date: 2026-06-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,276.32 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3, F4
• Acquired 0 shares of Phantom Stock (Derivative)
  Date: 2026-06-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,276.78 | transaction_form_type: 4 | Footnotes: F1, F5, F3, F3, F4

Footnotes:

• F1: 1-for-1
• F2: Dividend equivalent rights accrued to previously granted phantom stock awards under the Amended and Restated 2002 Equity Compensation Plan of EnPro Industries, Inc.
• F3: Vesting and payout occurs on the earliest of death, disability or the vesting and payout of the underlying award with respect to which the dividend equivalents relate.
• F4: Balance includes multiple phantom stock grants, phantom stock accruals and previously accrued dividend equivalents.
• F5: Dividend equivalent rights accrued to previously acquired phantom stock under the Deferred Compensation Plan for Non-Employee Directors (as amended and restated) of EnPro Industries, Inc.